Rani Therapeutics Holdings Inc Asset Turnover Ratio (RANI), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Rani Therapeutics Holdings Inc   (NASDAQ: RANI)
 

Rani Therapeutics Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Rani Therapeutics Holdings Inc asset turnover ratio, the ability of Rani Therapeutics Holdings Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.11 in the third quarter (Sep 30 2026), RANI's balance sheet remain strong.

Within sector Rani Therapeutics Holdings Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RANI Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 422.3 % 267.59 % 138.49 % 125.68 % -72.54 %
Y / Y Revenue Change - - 893.02 % 42.12 % -
Asset Turnover Ratio (TTM) 0.11 0.1 0.08 0.05 -
RANI's Total Ranking # # # # #
Seq. Asset Change -14.75 % 7.96 % -21.05 % 618.76 % -40 %
Seq. Revenue Change -0.06 % 0 % 16.91 % - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




RANI Company Profile • Back to RANI Efficiency Comparisons • Compare RANI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Biogen Inc   0.33 $ 10,297.300  Millions$ 30,765.825  Millions
Krystal Biotech Inc   0.32 $ 470.025  Millions$ 1,454.366  Millions
Hyperfine Inc   0.31 $ 18.537  Millions$ 59.098  Millions
Orasure Technologies Inc  0.31 $ 116.113  Millions$ 373.089  Millions
Pfizer Inc  0.31 $ 63,625.000  Millions$ 205,363.250  Millions
Cardiff Lexington Corporation  0.30 $ 9.066  Millions$ 30.160  Millions
Ionis Pharmaceuticals Inc   0.30 $ 960.091  Millions$ 3,220.224  Millions
Adc Therapeutics Sa  0.30 $ 84.873  Millions$ 287.472  Millions
Sonida Senior Living Inc   0.29 $ 638.130  Millions$ 2,170.454  Millions
Alpha Cognition Inc.  0.29 $ 20.197  Millions$ 69.375  Millions
Fulgent Genetics Inc   0.29 $ 329.873  Millions$ 1,134.512  Millions
Bio Green Med Solution Inc   0.29 $ 2.234  Millions$ 7.770  Millions
Waters Corporation  0.29 $ 5,611.362  Millions$ 19,618.388  Millions
Orchestra Biomed Holdings Inc   0.28 $ 31.206  Millions$ 109.738  Millions
Amarin Corp Plcuk  0.27 $ 176.609  Millions$ 643.746  Millions
Repligen Corp  0.27 $ 805.610  Millions$ 2,939.265  Millions
Humacyte Inc   0.27 $ 32.703  Millions$ 122.646  Millions
Neogen Corporation  0.26 $ 884.120  Millions$ 3,363.009  Millions
Autolus Therapeutics Plc  0.26 $ 137.434  Millions$ 533.104  Millions
Cryoport inc   0.25 $ 192.439  Millions$ 758.937  Millions
Bio rad Laboratories Inc   0.25 $ 2,593.000  Millions$ 10,350.400  Millions
Revvity Inc  0.25 $ 2,941.761  Millions$ 11,925.295  Millions
Coherus Oncology inc   0.24 $ 53.639  Millions$ 221.663  Millions
Assembly Biosciences Inc   0.23 $ 67.012  Millions$ 287.304  Millions
Sutro Biopharma Inc   0.23 $ 45.107  Millions$ 196.732  Millions
Seastar Medical Holding Corp  0.22 $ 2.165  Millions$ 9.845  Millions
Abeona Therapeutics Inc   0.22 $ 41.912  Millions$ 192.374  Millions
Beyond Air Inc   0.21 $ 7.299  Millions$ 35.326  Millions
Atara Biotherapeutics Inc   0.20 $ 4.019  Millions$ 19.966  Millions
4d Molecular Therapeutics Inc   0.19 $ 96.063  Millions$ 500.245  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.